About
Dr. Steven Quay,
MD, PHD
Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.
He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.
His current passion is the prevention of the two million yearly breast cancer cases worldwide.
2024 Media Kit
Welcome to the media guide for Dr. Steven Quay. Here you can find approved headshots, logos, bios, and other information to promote Dr. Quay for your show, podcast or event. He is a highly knowledgeable and experienced speaker, making him an excellent choice for any occasion. By downloading the approved content below, you will have everything you need to effectively promote Dr. Quay and ensure a successful event.
Media Kit includes:
- Approved Headshots
- Logo Files (PNG)
- Biography
- Distinguished Alumnus, Department of Biological Chemistry, The University of Michigan, 2015
- Entrepreneur of the Year, Northwest, Ernst & Young, 2005, Nastech Pharmaceuticals
- First Distinguished Alumnus, Biological Sciences Dept., Western Michigan University
- Entrepreneur of the Year, Northwest, Ernst & Young, 1998, Sonus Pharmaceuticals
- Distinguished Alumnus, Western Michigan University
- Dean’s Research Award, The University of Michigan Medical School
- Merrill Wiseman Award in Biology, Western Michigan University
- Iron-based MRI imaging agents
- Alzheimer’s Disease imaging agents
- Non-ionic MRI imaging agents
- Vitamin B6-mimetic MRI contrast agents for liver-specific imaging
- Improvements in MRI safety
- Vitamin B6 nuclear medicine imaging agent
- The foundational invention in the field of ultrasound contrast agents, fluorocarbon gases
- Diagnosing infertility by MRI
- Medical device for non-invasive breast cytology test
- Cancer emulsion formulations for improved efficacy
- Nasal spray to prevent breast cancer
- Peptide nasal spray for treating obesity
- Nascobal, a vitamin B12 nasal spray
- Parathyroid hormone nasal spray for treating osteoporosis
- Carbetocin nasal spray for treating autism
- Peptide drug discovery platform: The Trp Cage Phage Display
- Second generation Omega-3 formulations
- An RNAi drug and drug delivery platform
- Ophthalmic drops for the treatment of keratoconus
- Quorum-sensing vaccines for treating intractable infections